| [1] |
Sikorski C, Mavromanoli A C, Manji K, et al. Adverse childhood experiences and primary headache disorders: a systematic review, meta-analysis, and application of a biological theory[J]. Neurology, 2023, 101(21): e2151-e2161. DOI: 10.1212/WNL.0000000000207910.
|
| [2] |
Karsan N, Goadsby P J. Biological insights from the premonitory symptoms of migraine[J]. Nat Rev Neurol, 2018, 14(12): 699-710. DOI: 10.1038/s41582-018-0098-4.
|
| [3] |
Lund N L T, Petersen A S, Fronczek R, et al. Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments—a consensus article[J]. J Headache Pain, 2023, 24(1): 121. DOI: 10.1186/s10194-023-01660-8.
|
| [4] |
Yu S Y, Cao X T, Zhao G, et al. The burden of headache in China: validation of diagnostic questionnaire for a population-based survey[J]. J Headache Pain, 2011, 12(2): 141-146. DOI: 10.1007/s10194-011-0336-2.
|
| [5] |
Karsan N, Prabhakar P, Goadsby P J. Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service[J]. J Headache Pain, 2016, 17(1): 94. DOI: 10.1186/s10194-016-0689-7.
|
| [6] |
Schulte L H, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks[J]. Brain, 2016, 139(Pt 7): 1987-1993. DOI: 10.1093/brain/aww097.
|
| [7] |
Wang X L, Yin Z M, Lian Y J, et al. Premonitory symptoms in migraine from China: a multi-clinic study of 4821 patients[J]. Cephalalgia, 2021, 41(9): 991-1003. DOI: 10.1177/0333102421997850.
|
| [8] |
|
| [9] |
Headache Classification Committee of the International Headache Society IHS. The international classification of headache disorders, 3rd edition[J]. Cephalalgia, 2018, 38(1): 1-211. DOI: 10.1177/0333102417738202.
|
| [10] |
Vetvik K G, Macgregor E A. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine[J]. Lancet Neurol, 2017, 16(1): 76-87. DOI: 10.1016/S1474-4422(16)30293-9.
|
| [11] |
|
| [12] |
|
| [13] |
Vetvik K G, Macgregor E A. Menstrual migraine: a distinct disorder needing greater recognition[J]. Lancet Neurol, 2021, 20(4): 304-315. DOI: 10.1016/S1474-4422(20)30482-8.
|
| [14] |
Burish M J, Pearson S M, Shapiro R E, et al. Cluster headache is one of the most intensely painful human conditions: results from the International Cluster Headache Questionnaire[J]. Headache, 2021, 61(1): 117-124. DOI: 10.1111/head.14021.
|
| [15] |
Li K, Sun S P, Xue Z Y, et al. Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients[J]. J Headache Pain, 2022, 23(1): 92. DOI: 10.1186/s10194-022-01459-z.
|
| [16] |
|
| [17] |
Goadsby P J, Ailani J, Dodick D W, et al. Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial[J]. Nat Med, 2025, 31(7): 2179-2185. DOI: 10.1038/s41591-025-03679-7.
|
| [18] |
Ashina S, Mitsikostas D D, Lee M J, et al. Tension-type headache[J]. Nat Rev Dis Primers, 2021, 7: 24. DOI: 10.1038/s41572-021-00257-2.
|
| [19] |
|
| [20] |
|
| [21] |
Grech O, Mollan S P, Wakerley B R, et al. The role of metabolism in migraine pathophysiology and susceptibility[J]. Life, 2021, 11(5): 415. DOI: 10.3390/life11050415.
|
| [22] |
Grech O, Sassani M, Terwindt G, et al. Alterations in metabolic flux in migraine and the translational relevance[J]. J Headache Pain, 2022, 23(1): 127. DOI: 10.1186/s10194-022-01494-w.
|